Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide

In order to evaluate the main adverse effects of drug protocols using bortezomib and/or thalidomide for the treatment of multiple myeloma, we conducted a prospective study. Data were collected through interviews, clinical observation, and from hospital records. A total of 59 patients were included....

Full description

Bibliographic Details
Published in:Brazilian Journal of Medical and Biological Research
Main Authors: T.B.M. Castro, A.E. Hallack Neto, A. Atalla, L.C. Ribeiro
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2016-05-01
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600705&tlng=en